l-carnitine tmao nature medicine 2013 koeth γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Frontiers | The gut microbial
Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases l carnitine tmao nature medicine 2013 koeth Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Cardiovascular risk of dietary trimethylamine Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Meat metabolizing bacteria in atherosclerosis Nature Medicine Trimethylamine N Oxide and Related Gut Microbe Derived Metabolites and Incident Heart Failure Development in Community Based Populations Circulation: Heart Failure
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18




